Literature DB >> 15072499

Current trends in the management of carcinoma penis--a review.

Iqbal Singh1, A Khaitan.   

Abstract

UNLABELLED: AIMS AND
INTRODUCTION: To review the current literature, recent advances and recent trends in the management of squamous cell carcinoma of the penis so as to have a broad overview of penile cancer and its current management. The review was considered keeping in mind that squamous penile carcinoma is an infrequently encountered malignancy and that the etiology is still unclear though certain predisposing conditions are known to exist and also that controversy still exists as to the appropriate management of inguinal adenopathy. We also reviewed the etiological factors, clinical presentation, diagnosis, staging, prognostic factors in addition to management and prophylaxis.
METHODS: A literature search was carried out from Pubmed for indexed articles published over the last 50 years using the key words 'Management penile carcinoma', 'Squamous cell carcinoma penis' and 'inguinal lymphadenectomy'.
RESULTS: The search yielded over 1500 indexed published articles and reports. Important major reports and studies were reviewed, screened and tracked for recent changes and trends in the management of penile cancer. These were analyzed, tabulated and discussed.
CONCLUSIONS: Newer approaches to the management of penile cancer include use of laser, photodynamic therapy, neoadjuvant therapy and sentinel node mapping by lympho-gamma-scintigraphy. The current approach towards managing inguinal adenopathy shows an increasing trend towards the use of these newer modalities as well as the use of certain modifications in lympadenectomy such as (the use of ligasure, modified dissection, saphenous vein sparing and lymphoscintigraphy, etc.) thereby making the procedure considerably less morbid than before.

Entities:  

Mesh:

Year:  2003        PMID: 15072499     DOI: 10.1023/b:urol.0000020339.92722.33

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  84 in total

1.  Cancer of the penis.

Authors:  M RIVEROS; R GOROSTIAGA
Journal:  Arch Surg       Date:  1962-09

2.  Proceedings: Carcinoma of the penis.

Authors:  J B de Kernion; P Tynberg; L Persky; J P Fegen
Journal:  Cancer       Date:  1973-11       Impact factor: 6.860

3.  [Carcinoma of the penis: radiotherapy].

Authors:  F Bertoni
Journal:  Arch Ital Urol Androl       Date:  1996-06

4.  Profile of malignancies at Medical College, Ambajogai--(15 years retrospective study).

Authors:  P V Kulkarni; S S Jaiswal; S B Rathod; A Khalique; R R Kulkarni
Journal:  Indian J Cancer       Date:  1996-03       Impact factor: 1.224

5.  Surgical treatment of penile carcinoma: our experience from 1976 to 1997.

Authors:  V Ficarra; A D'Amico; S Cavalleri; G Zanon; A Mofferdin; D Schiavone; G Malossini; G Mobilio
Journal:  Urol Int       Date:  1999       Impact factor: 2.089

6.  Results and 10-year follow-up in patients with squamous cell carcinoma of the penis.

Authors:  P Derakhshani; S Neubauer; M Braun; H Bargmann; A Heidenreich; U Engelmann
Journal:  Urol Int       Date:  1999       Impact factor: 2.089

7.  First experience with gamma probe guided sentinel lymph node surgery in penile cancer.

Authors:  F Wawroschek; H Vogt; D Bachter; D Weckermann; M Hamm; R Harzmann
Journal:  Urol Res       Date:  2000-08

8.  Squamous cell carcinoma of the penis. III. Treatment of regional lymph nodes.

Authors:  S Horenblas; H van Tinteren; J F Delemarre; L M Moonen; V Lustig; E W van Waardenburg
Journal:  J Urol       Date:  1993-03       Impact factor: 7.450

9.  Carcinoma of the penis: improved survival by early regional lymphadenectomy based on the histological grade and depth of invasion of the primary lesion.

Authors:  W S McDougal
Journal:  J Urol       Date:  1995-10       Impact factor: 7.450

10.  Penile cancer: relation of extent of nodal metastasis to survival.

Authors:  V Srinivas; M J Morse; H W Herr; P C Sogani; W F Whitmore
Journal:  J Urol       Date:  1987-05       Impact factor: 7.450

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.